Collection
Genetic Models of Rare Diseases
Genes and variants of interest in rare diseases often benefit from modelling in cellular assays or genetic models to aid in understanding molecular and cellular mechanisms of disfunction. Model organisms are useful for the discovery of new genetic diseases and key to understanding variant effects, and modelling a disease gene in a genetic model means that researchers can perform an in-depth exploration of gene or variant function. These studies can pinpoint disease mechanisms, reveal unanticipated gene functions, or elucidate specific existing pathways. Unravelling the mechanism(s) by which variants act can highlight potential therapeutic strategies to help patients.
The GSA Journals are pleased to publish a series highlighting ongoing advances in rare disease discovery and mechanisms by presenting key research findings and new discoveries.
Overseen by Series Editors Brenda Andrews (University of Toronto), Hugo Bellen (Baylor College of Medicine), Douglas Fowler (University of Washington School of Medicine), and Philip Hieter (University of British Columbia), this series launched in August 2023 with an accompanying editorial and a block of 9 research papers. Authors are invited to submit manuscripts to the series on an ongoing basis.
Philip Hieter and others

To highlight the development of new model systems, assays, and resources designed to illuminate rare disease gene function, the Genetics Society of America has launched a special collection of publications in the GSA journals
GENETICS and
G3:
Genes|
Genomes|
Genetics.
Michael J Gruss and others

TWIST1 is a basic helix-loop-helix (bHLH) transcription factor in humans that functions in mesoderm differentiation. TWIST1 primarily regulates genes as a transcriptional repressor often through TWIST-Box domain-mediated protein–protein interactions.
Sarah E Wetzel-Strong and others

Sturge–Weber Syndrome (SWS) is a sporadic (non-inherited) syndrome characterized by capillary vascular malformations in the facial skin, leptomeninges, or the choroid. A hallmark feature is the mosaic nature of the phenotype.
Mary L Kaldunski and others

Rare diseases individually affect relatively few people, but as a group they impact considerable numbers of people. The Rat Genome Database (
https://rgd.mcw.edu) is a knowledgebase that offers resources for rare disease research.
Mary Bergwell and others

The human SASS6(I62T) missense mutation has been linked with the incidence of primary microcephaly in a Pakistani family, although the mechanisms by which this mutation causes disease remain unclear.
Rebecca A MacPherson and others

Switch/sucrose nonfermentable (SWI/SNF)-related intellectual disability disorders (SSRIDDs) and Cornelia de Lange syndrome are rare syndromic neurodevelopmental disorders with overlapping clinical phenotypes.
Sharayu V Jangam and others

EZH1, a polycomb repressive complex-2 component, is involved in a myriad of cellular processes. EZH1 represses transcription of downstream target genes through histone 3 lysine27 (H3K27) trimethylation (H3K27me3). Genetic variants in histone modifiers have been associated with developmental disorders, while EZH1 has not yet been linked to any human disease.
Xu Cao and others

Loss-of-function mutations of FIG4 are responsible for neurological disorders in human and mouse that result from reduced abundance of the signaling lipid PI(3,5)P2.
Maria C Sterrett

The RNA exosome is a conserved molecular machine that processes/degrades numerous coding and non-coding RNAs. The 10-subunit complex is composed of three S1/KH cap subunits (human EXOSC2/3/1; yeast Rrp4/40/Csl4), a lower ring of six PH-like subunits (human EXOSC4/7/8/9/5/6; yeast Rrp41/42/43/45/46/Mtr3), and a singular 3′-5′ exo/endonuclease DIS3/Rrp44.
Mark J Swanson and others

Alzheimer's disease (AD) is an age-related disorder that results in progressive cognitive impairment and memory loss. Deposition of amyloid β (Aβ) peptides in senile plaques is a hallmark of AD.
Natalie Hammond and others

Niemann–Pick type C (NP-C) disease is a rare lysosomal storage disease caused by mutations in NPC1 (95% cases) or NPC2 (5% cases). These proteins function together in cholesterol egress from the lysosome, whereby upon mutation, cholesterol and other lipids accumulate causing major pathologies.